Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer

被引:10
|
作者
Gupta, Swati [1 ]
Mani, Navin R. [1 ]
Carvajal-Hausdorf, Daniel E. [1 ,2 ]
Bossuyt, Veerle [1 ]
Ho, Kenneth [3 ]
Weidler, Jodi [4 ]
Wong, Wendy [3 ]
Rhees, Brian [3 ]
Bates, Michael [4 ]
Rimm, David L. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[2] Univ Desarrollo, Fac Med, Clin Alemana, Anat Patol, Santiago, Chile
[3] Cepheid, Div Oncol Res & Dev, Oncol, Sunnyvale, CA USA
[4] Cepheid, Med & Sci Affairs & Strategy, Oncol, Sunnyvale, CA USA
关键词
MESSENGER-RNA; IN-SITU; IMMUNOHISTOCHEMISTRY; CARCINOMA; TAMOXIFEN; ASSAY;
D O I
10.1038/s41374-018-0064-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An on-demand, closed RT-qPCR, the GeneXpert (GX) system, has the potential to provide biomarker information in low-resourced settings and elsewhere. We used this system with a research use only version of the Breast Cancer STRAT4 cartridge that measures the mRNA expression levels of ERBB2, ESR1, PGR, and MKi67. Here we evaluated the impact of non-macrodissected (non m-d) versus macrodissected (m-d) samples using STRAT4 on formalin-fixed, paraffin-embedded (FFPE) core needle biopsies. Two cohorts were assessed: (1) 60 FFPE infiltrating ductal carcinoma (IDCA) cases and (2) 20 FFPE IDCA cases with ductal carcinoma in situ (DCIS) with a range of HER2 expression as determined by clinical immunohistochemistry and fluorescence in situ hybridization (IHC/FISH). We observed about half of the core needle biopsy area as invasive tumor in both IDCA (mean = 51.5%) and IDCA with DCIS (mean = 53.5%) cohorts, but also found the mRNA levels were independent of tumor area. We found excellent agreement of the mRNA transcript level between the paired samples, m-d versus non m-d, for ERBB2, ESR1, PGR, and MKi67 for both the IDCA and IDCA with DCIS cohorts. No significant difference (P > 0.99) was observed when we compared the mRNA transcript level between the paired samples m-d versus non m-d. In addition, we noted a significant concordance (P < 0.001) between RT-qPCR and IHC/FISH for HER2-positivity, ER-positivity, and PR-positivity, independent of specimen dissection. These data suggest that mRNA expression for ERBB2, ESR, and PGR is sufficiently low in surrounding tissue cells such that macrodissection is not required for assessment of key breast cancer mRNA markers and is independent of the amount of input tumor. This approach may be valuable in settings lacking pathology expertise or using specimen types, such as fine-needle aspirates, where it may be challenging to separate non-tumor from tumor tissue.
引用
收藏
页码:1076 / 1083
页数:8
相关论文
共 50 条
  • [41] Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Mueller, Volkmar
    Janni, Wolfgang
    Fehm, Tanja
    Wallwiener, Diethelm
    Pantel, Klaus
    Tewes, Mitra
    BMC CANCER, 2016, 16
  • [42] Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer
    Chung, YL
    Sheu, ML
    Yang, SC
    Lin, CH
    Yen, SH
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (03) : 306 - 312
  • [43] Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
    Ramadan, Wafaa S.
    Vazhappilly, Cijo George
    Saleh, Ekram M.
    Menon, Varsha
    AlAzawi, Aya M.
    El-Serafi, Ahmed T.
    Mansour, Wael
    El-Awady, Raafat
    CANCERS, 2019, 11 (01)
  • [44] Protein Microarray-based Comparison of HER2, Estrogen Receptor, and Progesterone Receptor Status in Core Biopsies and Surgical Specimens From FFPE Breast Cancer Tissues
    Berg, Daniela
    Langer, Rupert
    Tran, Kai
    Walch, Axel
    Schuster, Tibor
    Bronger, Holger
    Becker, Karl-Friedrich
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011, 19 (04) : 300 - 305
  • [45] Correlation of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR) expression as predicted by core biopsy with the immunohistochemical results of surgical breast cancer specimens
    Erggelet, Julian
    Grosse, Regina
    Holzhausen, Hans-Juergen
    Hauptmann, Steffen
    Thomssen, Christoph
    BREAST CARE, 2007, 2 (02) : 94 - 98
  • [46] Atypical Co-amplification with Co-localization of HER2 Gene in Breast Cancer: Combined IHC/FISH Approach as per ASCO/CAP 2018 Guidelines for Targeted Therapy Eligibility
    Kate, Ushang
    Pais, Anurita
    Kamble, Neelam
    Kandoor, Sandhya
    Sharma, Kunal
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (01) : 8 - 11
  • [47] Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research
    Alqaisi, Abeer
    Chen, Li
    Romond, Edward
    Chambers, Mara
    Stevens, Mark
    Pasley, Grace
    Awasthi, Mukta
    Massarweh, Suleiman
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (02) : 437 - 444
  • [48] Atypical Co-amplification with Co-localization of HER2 Gene in Breast Cancer: Combined IHC/FISH Approach as per ASCO/CAP 2018 Guidelines for Targeted Therapy Eligibility
    Ushang Kate
    Anurita Pais
    Neelam Kamble
    Sandhya Kandoor
    Kunal Sharma
    Indian Journal of Surgical Oncology, 2024, 15 : 8 - 11
  • [49] Quantitative Determination of Estrogen Receptor, Progesterone Receptor, and HER2 mRNA in Formalin-fixed Paraffin-embedded Tissue-A New Option for Predictive Biomarker Assessment in Breast Cancer
    Mueller, Berit Maria
    Kronenwett, Ralf
    Hennig, Guido
    Euting, Heike
    Weber, Karsten
    Bohmann, Kerstin
    Weichert, Wilko
    Altmann, Gabriela
    Roth, Claudia
    Winzer, Klaus-Juergen
    Kristiansen, Glen
    Petry, Christoph
    Dietel, Manfred
    Denkert, Carsten
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2011, 20 (01) : 1 - 10
  • [50] The Novel Role of Cytomorphology from Ultrasound-Guided Fine Needle Aspiration Cytology in Evaluating the Status of Prognostic Factors including Estrogen Receptor, Progesterone Receptor and HER2 in Breast Cancer
    Li, Yunzhu
    Jia, Shijun
    Yao, Yuqi
    Zhou, Yehan
    Li, Shurong
    Li, Jiayu
    Liu, Yang
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022